Medical and healthcare service battlefield is heating up in China with the fast approaching of aging society, more favorable policies from the government as well as the rise of Internet.
Chinese medical app developer Chunyu has closed a massive US$50 million Series C financing from CICC, Rushan Venture Capital under DunAn Group, Pavilion Capital run by Temasek, with participation of Series A and Series B investor BlueRun Ventures, which injected several millions of dollars in this round.
Founded in 2011 by Zhang Rui, former director at CCTV and chief editor of NetEase, Chunyu is a mobile healthcare service that connects patients and doctors. The company’s flagship app Chunyu Doctor allows users to make inquiries to professional doctors about their potential diseases and symptoms for free. The firm also tapped into baby-care sector with vertical B2C healthcare product Chunyu Pediatrician last year.
Start your free trial now.
Get instant access to all our premium content, archives, newsletters, and online community.
Monthly Membership
Yearly Membership
What you get
Full access to all premium content and our full archives
Members'-only newsletters
Preferential access and discounts to all TechNode events
Direct access to the TechNode newsroom
Start your free trial now.
Get instant access to all our premium content, archives, newsletters, and online community.